Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up 1841 News Items found MSK Healthcare Heroes Roll Up Their Sleeves to Receive the COVID-19 Vaccine Friday, December 18, 2020 Help save lives. Get immunized. Q&A Targeted Therapies, Immunotherapy, and Chemotherapy: What’s New in Breast Cancer? Friday, December 11, 2020 Learn about the latest trends in breast cancer research reported at this year’s SABCS meeting. In the Lab A Deeper Vision: How Digital Technology Is Aiding Breast Cancer Diagnosis Thursday, December 10, 2020 By training computers to detect pathological changes in slides of tumor tissue, digital pathology promises to help doctors provide better patient care. MSK Experts Featured at the 2020 ASH Annual Meeting and Exposition Friday, December 4, 2020 MSK physicians and scientists are involved in notable research to be presented at the meeting and are available to comment on a variety of topics within leukemia, lymphoma, and multiple myeloma. A Doctor Who Followed His Dream From Zimbabwe to MSK: Josh's Story Thursday, December 3, 2020 Read about Josh Foromera, who was born in a small village in Zimbabwe and recently began a fellowship in the Gastroenterology, Hepatology, and Nutrition Service at MSK. In the Clinic Unexpected Finding Reveals New Target for Aggressive Form of Lung Cancer Tuesday, December 1, 2020 Researchers discover that a subset of lung adenocarcinomas are aggressive because of mutations that allow them to block ferroptosis, a type of cell death. Wielding Powerful Imaging Tools, MSK Researchers Decipher Process of DNA Repair Tuesday, December 1, 2020 The high-resolution views provided by cryo-electron microscopy are helping scientists learn how proteins and DNA collaborate to repair broken DNA. For People with Certain BRCA Mutations, Activating the Immune System Could Be Promising Treatment Monday, November 30, 2020 Human data and results from mouse experiments suggest that people with BRCA2 mutations may respond well to immunotherapy drugs. In the Clinic A Perfect Match: Molecular Tests Developed at MSK Guide Personalized Treatment for Lung Cancer Wednesday, November 25, 2020 For personalized treatment to work, it’s important to analyze each person’s tumor for genetic mutations and find the best drugs to target those mutations. Finding MSK Study Is the First to Link Microbiota to Dynamics of the Human Immune System Wednesday, November 25, 2020 MSK researchers have shown for the first time that the concentration of different types of immune cells in the blood changes in relation to the presence of different bacterial strains in the gut. Pagination Load More Book traversal links for Newsroom Previous Newsroom Next Cancer Vaccine Could Prevent Neuroblastoma From Returning After Antibody Treatment